Autologous Adipose-Derived Stem Cell Transplantation in Patients With Lipodystrophy

Phase 1

• Conditions: Lipodystrophy

• Registration Number: NCT00715546
• Lead Sponsor: Irmandade Santa Casa de Misericórdia de Porto Alegre

Brief Summary

The aim of this study is to determine the safety of the autologous transplantation of adipose-derived stem cells in the treatment of lipodystrophies.

Detailed Description

Not available

Study Timeline

• Study Start: 2007-10
• Study First Submitted: 2008-07-11
• Study First Submitted QC: 2008-07-12
• Study First Posted: 2008-07-15
• Status Verified: 2009-03
• Last Update Submitted: 2011-06-21
• Last Update Posted: 2011-06-22
• Primary Completion: 2011-08
• Study Completion: 2011-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 5

Inclusion Criteria

• lipodystrophies with necessity of fat grafting
• accept to participate of the study

Exclusion Criteria

• HIV infection
• Metastatic malignancy
• Body mass index < 20 kg/m²
• Other severe systemic disease

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Clinical evaluation of the transplanted area.	one year

Secondary Outcome Measures

Name	Time	Method
Presence of neovascularization, adipose transplantation reabsorption, tissue viability	one year

Trial Locations

Locations (1)

Irmandade Santa Casa de Misericórdia; 🇧🇷 Porto Alegre, Rio Grande do Sul, Brazil